Dihexa vs IllumiNeuro Protocol
Emerging vs Limited Research
monitor Researched · 90% Both highly neuroactive; use caution combining multiple cognitive enhancers.
Molecular Data
Dihexa IllumiNeuro Protocol
Weight 504.7 Da —
Half-life 8-12 days —
Type Modified oligopeptide Fixed-ratio peptide combination
Key Benefits
Dihexa
01 Dramatic synaptogenesis promotion
02 10 million times more potent than BDNF
03 Cognitive enhancement and memory improvement
04 Neuroprotection and potential neuroregeneration
05 Applications for Alzheimer's, TBI, age-related cognitive decline
06 Oral bioavailability
IllumiNeuro Protocol
01 Multi-pathway cognitive enhancement
02 Neuroprotective and neuritogenic effects
03 Anxiolytic properties from NA-Selank
04 BDNF upregulation from NA-Semax
05 Circadian/sleep support from Pinealon
06 Convenience of single injection
07 Extended-action amidate forms included
Dosing Protocols
Dihexa
8-10mg oral or 2-5mg injectable (0.5mg/kg based on research) / Once daily in the morning
Research protocol 0.5mg/kg daily Daily or 3x weekly
Standard injectable 2-5mg total 1x daily
IllumiNeuro Protocol
100-500 mcg total blend per day / Once daily, preferably in the morning for cognitive benefits
Conservative cognitive support 100-200mcg total blend Once daily (morning)
Standard protocol 200-400mcg total blend Once daily
Enhanced protocol 400-500mcg total blend Once daily
Side Effects
Dihexa
Headaches (most frequent side effect)
Anxiety or overstimulation
Sleep disruption when dosed late in day
Mental clarity increase
IllumiNeuro Protocol
Injection site reactions (mild)
Nasal irritation if used intranasally
Possible vivid dreams (Pinealon effect)
Mild headache initially
Contraindications
Not FDA approved - research compound only
Theoretical cancer risk via c-Met activation
Cancer history (avoid due to c-Met pathway)
Pregnancy or breastfeeding
No long-term human safety data
No clinical trials on four-peptide combination
Bipolar disorder or psychosis (caution with cognitive enhancers)
Pregnancy or breastfeeding
Seizure disorders (theoretical concern)
Research Evidence
Dihexa IllumiNeuro Protocol
Status Emerging Limited Research
References 4 studies 4 studies
Latest 2024 —
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.